Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L3 pseudogene 6 (RPL3P6)
- Target
- RPL3P6
- Molecular classification
- Other (Pseudogene)
01
Overview
RPL3P6 (ribosomal protein L3 pseudogene 6) is a processed pseudogene in the human genome derived from the active ribosomal protein L3 gene (RPL3)[2][7][9]. Pseudogenes like RPL3P6 do not produce functional proteins and are remnants of gene duplication or retrotransposition events[8]. While the parental RPL3 gene encodes a key ribosomal protein involved in translation for the large 60S subunit, the pseudogene has no known biological function, clinical role, or therapeutic relevance[2][8][9].
- Other names
- RPL3_2_568RPL3P6
02
Mechanism of action
null
Beyond the preview
Go deeper on Ribosomal protein L3 pseudogene 6 (RPL3P6).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ribosomal protein L3 pseudogene 6 (RPL3P6).